Heights Capital Management »

Moonlake Immunot shares owned by Heights Capital Management

Quarter-by-quarter ownership of Moonlake Immunot (MLTX) shares owned by Heights Capital Management from 13F filings

Historical chart of Heights Capital Management investment in Moonlake Immunot

Tip: Access up to 7 years of quarterly data

All positions including Moonlake Immunot held by Heights Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Moonlake Immunot by Heights Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.9M 100k 19.47

More positions owned by Heights Capital Management

Flutter Entmt SHS (FLUT)
Amc Entmt Hldgs Cl A New (AMC)
Meiragtx Holdings (MGTX)
Taysha Gene Therapies Com Shs (TSHA)
Starlink Ai Acquisition Corp Unit 99/99/9999
Ch4 Natural Solutions Corp Ord Shs Cl A
Jackson Acquisition Co Ii Com Shs Cl A (JACS)
Jab Acquisition Corp I Unit 06/05/2031
Drugs Made In Amer Acqutn Ord Shs (DMAA)
Toyo Ord Sh (TOYO)
Snow Rothschild Acquisition Unit 05/22/2031
Gores Holdings Xi Unit 06/24/2031
Iron Dome Acquisition I Corp Unit 02/27/2031
Alpex Acquisition Corp Unit 06/05/2031
Pono Cap Four Cl A Ord Shs

View all positions for Heights Capital Management

Top funds holding Moonlake Immunot

BVF
Deep Track Capital
Henderson Group
D. E. Shaw & Co
Cormorant Asset Management
Jupiter Topco
Logos Global Management
Weiss Asset Management LP[1
Citadel Advisors
Two Sigma Investments
MPM Oncology Impact Management
Vivo Capital
Jpmorgan Chase & Co
T. Rowe Price Associates
Jane Street

View all funds holding Moonlake Immunot